InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

- Current share price for RHY : $0.081

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$29 Release of Restricted Securities from Escrow 6 Aug 2018 4:20PM $0.180 $0.081 fallen by 55%
$29 Appendix 4C 30 Jul 2018 2:12PM $0.190 $0.081 fallen by 57.37%
$29 Rhythm completes cloning of key reagent ahead of schedule 21 Jun 2018 9:28AM $0.255 $0.081 fallen by 68.24%
$29 Merchant Group increases stake in Rhythm from 5% to 7% 15 Jun 2018 8:54AM $0.220 $0.081 fallen by 63.18%
$29 RHY Welcomes Leading Biotech Fund as New Major Shareholder 12 Jun 2018 8:33AM $0.200 $0.081 fallen by 59.50%
$29 Appendix 3B 22 May 2018 4:29PM $0.170 $0.081 fallen by 52.35%
$29 Key Management Appointments at Rhythm Biosciences 22 May 2018 9:59AM $0.175 $0.081 fallen by 53.71%
$29 Rhythm Granted Biomarker Patent in Europe 16 May 2018 11:24AM $0.180 $0.081 fallen by 55%
$29 RHY's Four Antibodies Pass all Three Key Screening Tests 14 May 2018 11:10AM $0.180 $0.081 fallen by 55%
$29 Appendix 4C 30 Apr 2018 4:19PM $0.190 $0.081 fallen by 57.37%
$29 Reagent Development Update 24 Apr 2018 9:18AM $0.165 $0.081 fallen by 50.91%
$29 Change of Director's Interest Notice 23 Mar 2018 9:16AM $0.170 $0.081 fallen by 52.35%
$29 Appendix 4D - Half Yearly Report 1 Mar 2018 10:33AM $0.200 $0.081 fallen by 59.50%
$29 Half Yearly Report and Accounts 27 Feb 2018 2:38PM $0.185 $0.081 fallen by 56.22%
$29 Consultation with Major Diagnostic Labs Underway - Update 15 Feb 2018 9:47AM $0.190 $0.081 fallen by 57.37%
$29 Rhythm reports reagent development update 7 Feb 2018 11:59AM $0.190 $0.081 fallen by 57.37%
$29 Quarterly report and Appendix 4C 31 Jan 2018 8:57AM $0.230 $0.081 fallen by 64.78%
$29 CSIRO and Rhythm Commence Development of Key Reagents 24 Jan 2018 10:39AM $0.230 $0.081 fallen by 64.78%
$29 CSIRO to assist Rhythm Biosciences develop key reagents 9 Jan 2018 9:59AM $0.270 $0.081 fallen by 70%
$29 Becoming a substantial holder 7 Dec 2017 9:57AM n/a $0.081 n/a
$29 Becoming a substantial holder 7 Dec 2017 9:57AM n/a $0.081 n/a
$29 Appendix 3X - Lockett 6 Dec 2017 5:03PM n/a $0.081 n/a
$29 Appendix 3X - Tanner 6 Dec 2017 5:02PM n/a $0.081 n/a
$29 Appendix 3X - Panaccio 6 Dec 2017 5:01PM n/a $0.081 n/a
$29 Appendix 3X - White 6 Dec 2017 4:59PM n/a $0.081 n/a

601 - 625 of 639 results

Page 25 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.